- 現金殖利率: 1.74%、總殖利率: 1.74%、5年平均現金配發率: 76.88%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 0.80 | -80.25 | 0.70 | -76.67 | 0.00 | 0 | 87.50 | 18.12 | 0.00 | 0 | 87.50 | 18.12 |
| 2022 (9) | 4.05 | -60.49 | 3.00 | -60.0 | 0.00 | 0 | 74.07 | 1.23 | 0.00 | 0 | 74.07 | 1.23 |
| 2021 (8) | 10.25 | 216.36 | 7.50 | 212.5 | 0.00 | 0 | 73.17 | -1.22 | 0.00 | 0 | 73.17 | -1.22 |
| 2020 (7) | 3.24 | 11.34 | 2.40 | 9.09 | 0.00 | 0 | 74.07 | -2.02 | 0.00 | 0 | 74.07 | -2.02 |
| 2019 (6) | 2.91 | -56.24 | 2.20 | -56.0 | 0.00 | 0 | 75.60 | 0.55 | 0.00 | 0 | 75.60 | 0.55 |
| 2018 (5) | 6.65 | -3.2 | 5.00 | -1.96 | 0.00 | 0 | 75.19 | 1.28 | 0.00 | 0 | 75.19 | 1.28 |
| 2017 (4) | 6.87 | 11.53 | 5.10 | 13.33 | 0.00 | 0 | 74.24 | 1.62 | 0.00 | 0 | 74.24 | 1.62 |
| 2016 (3) | 6.16 | 36.89 | 4.50 | 36.36 | 0.00 | 0 | 73.05 | -0.38 | 0.00 | 0 | 73.05 | -0.38 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 0.01 | -95.45 | -98.18 | 0.09 | 80.0 | 200.0 | 0.38 | 0.0 | -51.28 |
| 24Q2 (19) | 0.22 | 37.5 | 83.33 | 0.05 | 135.71 | 126.32 | 0.38 | 137.5 | 65.22 |
| 24Q1 (18) | 0.16 | 700.0 | 45.45 | -0.14 | -193.33 | 0 | 0.16 | -80.0 | 45.45 |
| 23Q4 (17) | 0.02 | -96.36 | 125.0 | 0.15 | 266.67 | -53.12 | 0.80 | 2.56 | -80.25 |
| 23Q3 (16) | 0.55 | 358.33 | 27.91 | -0.09 | 52.63 | -400.0 | 0.78 | 239.13 | -81.11 |
| 23Q2 (15) | 0.12 | 9.09 | -93.37 | -0.19 | 0 | -121.59 | 0.23 | 109.09 | -93.8 |
| 23Q1 (14) | 0.11 | 237.5 | -94.21 | 0.00 | -100.0 | -100.0 | 0.11 | -97.28 | -94.21 |
| 22Q4 (13) | -0.08 | -118.6 | -103.64 | 0.32 | 966.67 | -84.31 | 4.05 | -1.94 | -60.49 |
| 22Q3 (12) | 0.43 | -76.24 | -85.27 | 0.03 | -96.59 | -98.77 | 4.13 | 11.32 | -48.7 |
| 22Q2 (11) | 1.81 | -4.74 | -37.8 | 0.88 | -31.78 | -66.54 | 3.71 | 95.26 | -27.68 |
| 22Q1 (10) | 1.90 | -13.64 | -14.8 | 1.29 | -36.76 | -29.89 | 1.90 | -81.46 | -14.8 |
| 21Q4 (9) | 2.20 | -24.66 | 42.86 | 2.04 | -16.39 | 47.83 | 10.25 | 27.33 | 216.36 |
| 21Q3 (8) | 2.92 | 0.34 | 122.9 | 2.44 | -7.22 | 430.43 | 8.05 | 56.92 | 370.76 |
| 21Q2 (7) | 2.91 | 30.49 | 977.78 | 2.63 | 42.93 | 574.36 | 5.13 | 130.04 | 1182.5 |
| 21Q1 (6) | 2.23 | 44.81 | 1615.38 | 1.84 | 33.33 | 581.48 | 2.23 | -31.17 | 1615.38 |
| 20Q4 (5) | 1.54 | 17.56 | 196.15 | 1.38 | 200.0 | 272.97 | 3.24 | 89.47 | 11.34 |
| 20Q3 (4) | 1.31 | 385.19 | 0.0 | 0.46 | 17.95 | 0.0 | 1.71 | 327.5 | 0.0 |
| 20Q2 (3) | 0.27 | 107.69 | 0.0 | 0.39 | 44.44 | 0.0 | 0.40 | 207.69 | 0.0 |
| 20Q1 (2) | 0.13 | -75.0 | 0.0 | 0.27 | -27.03 | 0.0 | 0.13 | -95.53 | 0.0 |
| 19Q4 (1) | 0.52 | 0.0 | 0.0 | 0.37 | 0.0 | 0.0 | 2.91 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/10 | 227.58 | 6.2 | 4.76 | 2142.18 | -1.95 | 666.51 | N/A | - | ||
| 2024/9 | 214.28 | -4.61 | -3.22 | 1914.6 | -2.69 | 664.23 | 0.81 | - | ||
| 2024/8 | 224.64 | -0.29 | -4.79 | 1700.31 | -2.62 | 668.08 | 0.8 | - | ||
| 2024/7 | 225.31 | 3.29 | 4.72 | 1475.67 | -2.29 | 670.57 | 0.8 | - | ||
| 2024/6 | 218.13 | -3.96 | 10.21 | 1250.36 | -3.45 | 664.06 | 0.76 | - | ||
| 2024/5 | 227.14 | 3.81 | 0.53 | 1032.24 | -5.92 | 661.19 | 0.76 | - | ||
| 2024/4 | 218.8 | 1.64 | 2.45 | 805.1 | -7.59 | 601.17 | 0.84 | - | ||
| 2024/3 | 215.26 | 28.8 | -8.94 | 586.3 | -10.86 | 586.3 | 0.85 | - | ||
| 2024/2 | 167.11 | -18.05 | -23.49 | 371.04 | -11.93 | 572.71 | 0.87 | - | ||
| 2024/1 | 203.93 | 1.12 | 0.5 | 203.93 | 0.5 | 614.95 | 0.81 | - | ||
| 2023/12 | 201.67 | -3.67 | -15.75 | 2595.88 | -26.91 | 628.24 | 0.8 | - | ||
| 2023/11 | 209.35 | -3.62 | -16.93 | 2394.21 | -27.72 | 647.99 | 0.78 | - | ||
| 2023/10 | 217.22 | -1.89 | -18.42 | 2184.86 | -28.6 | 674.59 | 0.75 | - | ||
| 2023/9 | 221.41 | -6.16 | -18.32 | 1967.63 | -29.57 | 672.51 | 0.75 | - | ||
| 2023/8 | 235.96 | 9.67 | -14.22 | 1746.22 | -30.78 | 649.0 | 0.78 | - | ||
| 2023/7 | 215.15 | 8.71 | -23.08 | 1510.27 | -32.81 | 638.98 | 0.79 | - | ||
| 2023/6 | 197.9 | -12.4 | -38.44 | 1295.12 | -34.19 | 637.38 | 0.83 | - | ||
| 2023/5 | 225.93 | 5.79 | -31.29 | 1097.22 | -33.36 | 675.89 | 0.78 | - | ||
| 2023/4 | 213.55 | -9.67 | -28.09 | 871.29 | -33.88 | 668.39 | 0.79 | - | ||
| 2023/3 | 236.41 | 8.23 | -36.1 | 657.74 | -35.57 | 657.74 | 0.83 | - | ||
| 2023/2 | 218.43 | 7.65 | -26.75 | 421.33 | -35.26 | 660.71 | 0.82 | - | ||
| 2023/1 | 202.9 | -15.24 | -42.46 | 202.9 | -42.46 | 694.32 | 0.78 | - | ||
| 2022/12 | 239.39 | -5.01 | -30.7 | 3551.83 | -13.72 | 757.71 | 0.7 | - | ||
| 2022/11 | 252.04 | -5.35 | -30.08 | 3312.45 | -12.16 | 789.42 | 0.67 | - | ||
| 2022/10 | 266.28 | -1.77 | -28.9 | 3060.41 | -10.27 | 812.46 | 0.65 | - | ||
| 2022/9 | 271.1 | -1.44 | -24.08 | 2794.13 | -7.97 | 825.88 | 0.69 | - | ||
| 2022/8 | 275.08 | -1.65 | -26.49 | 2523.03 | -5.82 | 876.3 | 0.65 | - | ||
| 2022/7 | 279.71 | -13.0 | -23.98 | 2247.95 | -2.47 | 930.06 | 0.61 | - | ||
| 2022/6 | 321.52 | -2.22 | -7.07 | 1968.24 | 1.61 | 947.32 | 0.64 | - | ||
| 2022/5 | 328.83 | 10.72 | -4.64 | 1646.72 | 3.5 | 995.83 | 0.61 | - | ||
| 2022/4 | 296.97 | -19.74 | -14.91 | 1317.89 | 5.75 | 965.23 | 0.63 | - | ||
| 2022/3 | 370.02 | 24.07 | 7.65 | 1020.92 | 13.8 | 1020.92 | 0.58 | - | ||
| 2022/2 | 298.23 | -15.43 | 14.74 | 650.9 | 17.62 | 996.29 | 0.59 | - | ||
| 2022/1 | 352.67 | 2.1 | 20.17 | 352.67 | 20.17 | 1058.53 | 0.56 | - | ||
| 2021/12 | 345.39 | -4.18 | 21.9 | 4116.66 | 50.59 | 1080.39 | 0.53 | 全球疫情控制、景氣回溫等有利因素，本公司全年營收較去年大幅增加。 | ||
| 2021/11 | 360.47 | -3.75 | 37.0 | 3771.26 | 53.91 | 1092.1 | 0.53 | 今年疫情趨緩，全球消費動能回溫，本公司營收較去年同期大幅增加。 | ||
| 2021/10 | 374.53 | 4.87 | 51.39 | 3410.8 | 55.94 | 1105.85 | 0.52 | 去年肺炎疫情影響全球經濟活動；今年景氣大幅增溫，本公司營收較去年大幅增加。 | ||
| 2021/9 | 357.1 | -4.57 | 49.86 | 3036.27 | 56.53 | 1099.28 | 0.46 | 今年全球疫情逐漸得到控制，各國逐步施打疫苗，使民生需求強力反彈，各行業景氣顯著回溫，帶動本公司各項產品營收大幅增加。 | ||
| 2021/8 | 374.22 | 1.7 | 68.49 | 2679.17 | 57.46 | 1088.17 | 0.46 | 去年全球經濟活動正開始緩步復甦，而今年本公司處於營運高峰，相較之下，營收大幅增加。 | ||
| 2021/7 | 367.96 | 6.35 | 69.15 | 2304.95 | 55.8 | 1058.79 | 0.48 | 今年本公司處於營運高峰，而去年同期部分國家開始有條件解封，全球景氣剛開始由谷底爬升，因此兩相比較之下，營收大幅增加。 | ||
| 2021/6 | 345.99 | 0.33 | 66.38 | 1936.99 | 53.5 | 1039.88 | 0.46 | 去年新冠肺炎疫情嚴重，各國多處於封鎖狀態，景氣低迷，而今年營運良好，相較之下營收大幅增加。 | ||
| 2021/5 | 344.85 | -1.2 | 77.58 | 1591.0 | 50.96 | 1037.62 | 0.46 | 去年5月新冠肺炎疫情擴散，由亞洲進而蔓延至歐美，重創全球經濟活動，而今年5月公司營運良好，故相較之下差異較大。 | ||
| 2021/4 | 349.05 | 1.54 | 71.0 | 1246.15 | 44.95 | 952.68 | 0.51 | 2021年4月合併營收與去年比較大幅成長，主要係去年4月新冠肺炎疫情擴散，而今年4月公司營運處於高峰，故相較之下差異甚大。 | ||
| 2021/3 | 343.72 | 32.24 | 47.87 | 897.11 | 36.84 | 897.11 | 0.49 | - | ||
| 2021/2 | 259.92 | -11.43 | 29.96 | 553.38 | 30.78 | 836.66 | 0.53 | - | ||
| 2021/1 | 293.47 | 3.59 | 31.51 | 293.47 | 31.51 | 839.85 | 0.52 | - | ||
| 2020/12 | 283.28 | 7.66 | 18.49 | 2733.49 | -4.52 | 793.77 | 0.52 | - | ||
| 2020/11 | 263.1 | 6.35 | 11.77 | 2450.22 | -6.62 | 748.77 | 0.55 | - | ||
| 2020/10 | 247.39 | 3.82 | 2.22 | 2187.11 | -8.43 | 707.77 | 0.58 | - | ||
| 2020/9 | 238.28 | 7.28 | 1.22 | 1939.72 | -9.63 | 677.9 | 0.64 | - | ||
| 2020/8 | 222.1 | 2.1 | -6.6 | 1701.44 | -10.97 | 647.57 | 0.67 | - | ||
| 2020/7 | 217.52 | 4.6 | -11.44 | 1479.34 | -11.59 | 619.66 | 0.7 | - | ||
| 2020/6 | 207.95 | 7.08 | -5.43 | 1261.82 | -11.61 | 606.25 | 0.72 | - | ||
| 2020/5 | 194.19 | -4.86 | -21.66 | 1053.87 | -12.74 | 630.74 | 0.69 | - | ||
| 2020/4 | 204.11 | -12.19 | -18.59 | 859.69 | -10.44 | 636.55 | 0.68 | - | ||
| 2020/3 | 232.45 | 16.22 | -6.89 | 655.58 | -7.56 | 655.58 | 0.65 | - | ||
| 2020/2 | 199.99 | -10.37 | -4.57 | 423.13 | -7.92 | 662.59 | 0.64 | - | ||
| 2020/1 | 223.14 | -6.81 | -10.72 | 223.14 | -10.72 | 698.0 | 0.61 | - | ||
| 2019/12 | 239.47 | 1.73 | -3.48 | 2863.43 | -14.02 | 0.0 | N/A | - | ||
| 2019/11 | 235.39 | -2.72 | -7.23 | 2623.96 | -14.87 | 0.0 | N/A | - |
